244 related articles for article (PubMed ID: 30707172)
21. Sumoylation and Its Contribution to Cancer.
Lee JS; Choi HJ; Baek SH
Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation in Neurological Diseases.
Liu FY; Liu YF; Yang Y; Luo ZW; Xiang JW; Chen ZG; Qi RL; Yang TH; Xiao Y; Qing WJ; Li DW
Curr Mol Med; 2017; 16(10):893-899. PubMed ID: 28067168
[TBL] [Abstract][Full Text] [Related]
23. Small ubiquitin-related modifiers in chains.
Vertegaal AC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
[TBL] [Abstract][Full Text] [Related]
24. Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation.
Uchimura Y; Ichimura T; Uwada J; Tachibana T; Sugahara S; Nakao M; Saitoh H
J Biol Chem; 2006 Aug; 281(32):23180-90. PubMed ID: 16757475
[TBL] [Abstract][Full Text] [Related]
25. Heterologous expression of OsSIZ1, a rice SUMO E3 ligase, enhances broad abiotic stress tolerance in transgenic creeping bentgrass.
Li Z; Hu Q; Zhou M; Vandenbrink J; Li D; Menchyk N; Reighard S; Norris A; Liu H; Sun D; Luo H
Plant Biotechnol J; 2013 May; 11(4):432-45. PubMed ID: 23231430
[TBL] [Abstract][Full Text] [Related]
26. SUMO pathway components as possible cancer biomarkers.
Mattoscio D; Chiocca S
Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
[TBL] [Abstract][Full Text] [Related]
27. Moderate hypothermia induces protein SUMOylation in bone marrow stromal cells and enhances their tolerance to hypoxia.
Ren W; Ma X; Liu X; Li Y; Jiang Z; Zhao Y; Li C; Li X
Mol Med Rep; 2017 Nov; 16(5):7006-7012. PubMed ID: 28901483
[TBL] [Abstract][Full Text] [Related]
28. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice].
Zhao XY; Wang DD; Shan Y; Zhu CQ
Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181
[TBL] [Abstract][Full Text] [Related]
29. Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α.
Zhou Q; Zhang L; Chen Z; Zhao P; Ma Y; Yang B; He Q; Ying M
FEBS J; 2014 Jul; 281(13):3032-47. PubMed ID: 24819975
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
31. Global shifts in protein sumoylation in response to electrophile and oxidative stress.
Manza LL; Codreanu SG; Stamer SL; Smith DL; Wells KS; Roberts RL; Liebler DC
Chem Res Toxicol; 2004 Dec; 17(12):1706-15. PubMed ID: 15606148
[TBL] [Abstract][Full Text] [Related]
32. Large-Scale Purification of Small Ubiquitin-Like Modifier (SUMO)-Modified Proteins from
Nie M; Boddy MN
Cold Spring Harb Protoc; 2017 Mar; 2017(3):pdb.prot091603. PubMed ID: 28250213
[TBL] [Abstract][Full Text] [Related]
33. Nuclear receptor NR5A2 is involved in the calreticulin gene regulation during renal fibrosis.
Arvaniti E; Vakrakou A; Kaltezioti V; Stergiopoulos A; Prakoura N; Politis PK; Charonis A
Biochim Biophys Acta; 2016 Sep; 1862(9):1774-85. PubMed ID: 27345266
[TBL] [Abstract][Full Text] [Related]
34. SUMO E3 Ligase PIASy Mediates High Glucose-Induced Activation of NF-
Huang W; Liang Y; Dong J; Zhou L; Gao C; Jiang C; Chen M; Long Y; Xu Y
Mediators Inflamm; 2017; 2017():1685194. PubMed ID: 29038616
[TBL] [Abstract][Full Text] [Related]
35. The SUMO Pathway in Hematomalignancies and Their Response to Therapies.
Boulanger M; Paolillo R; Piechaczyk M; Bossis G
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405039
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of sumoylation prevents experimental fibrosis.
Khodzhigorova A; Distler A; Lang V; Dees C; Schneider H; Beyer C; Gelse K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Nov; 71(11):1904-8. PubMed ID: 22904261
[TBL] [Abstract][Full Text] [Related]
37. SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.
Tomasi ML; Ramani K
Transl Gastroenterol Hepatol; 2018; 3():20. PubMed ID: 29780898
[TBL] [Abstract][Full Text] [Related]
38. SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.
Vishwamitra D; Curry CV; Shi P; Alkan S; Amin HM
Neoplasia; 2015 Sep; 17(9):742-754. PubMed ID: 26476082
[TBL] [Abstract][Full Text] [Related]
39. MS-based strategies for identification of protein SUMOylation modification.
Sheng Z; Wang X; Ma Y; Zhang D; Yang Y; Zhang P; Zhu H; Xu N; Liang S
Electrophoresis; 2019 Nov; 40(21):2877-2887. PubMed ID: 31216068
[TBL] [Abstract][Full Text] [Related]
40. SUMO modification in apoptosis.
Li P; Jing H; Wang Y; Yuan L; Xiao H; Zheng Q
J Mol Histol; 2021 Feb; 52(1):1-10. PubMed ID: 33225418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
